Haohai Biological Technology: The holding subsidiary's triaxial curved surface artificial lens has obtained a registration certificate.

Haohai Biological announced that its holding subsidiary, Saimeishi, recently received the registration certificate from the National Medical Products Administration for its trifocal toric intraocular lens product, which is applicable for vision correction in adults with cataracts and corneal astigmatism in eyes without a natural lens, with a validity period until August 3, 2031. This product is the first domestically approved trifocal toric intraocular lens in China, and its approval deepens the company's layout in the high-end refractive intraocular lens sector. However, the product has not yet formed sales and will not have a significant impact on recent performance; future sales remain uncertain.